Errol B Desouza is of Cyclerion Therapeutics, Inc.. Currently has a direct ownership of 30,000 shares of CYCN, which is worth approximately $105,600. The most recent transaction as insider was on Nov 30, 2023, when has been sold 50,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 30K
0% 3M change
n/a 12M change
Total Value Held $105,600

ERROL B DESOUZA Transaction History

Date Transaction Value Shares Traded Shares Held Form
Nov 30 2023
BUY
Grant, award, or other acquisition
-
50,000 Added 62.5%
30,000 Common Stock

Also insider at

CBIO
CATALYST BIOSCIENCES, INC. Healthcare
RPRX
Royalty Pharma plc Healthcare
ALEC
Alector, Inc. Healthcare
EBD

Errol B Desouza

New York, NY

Track Institutional and Insider Activities on CYCN

Follow Cyclerion Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CYCN shares.

Notify only if

Insider Trading

Get notified when an Cyclerion Therapeutics, Inc. insider buys or sells CYCN shares.

Notify only if

News

Receive news related to Cyclerion Therapeutics, Inc.

Track Activities on CYCN